ADCT-301, a Pyrrolobenzodiazepine (PBD) Dimer-Containing Antibody-Drug Conjugate (ADC) Targeting CD25-Expressing Hematological Malignancies. (Q38734010)
Jump to navigation
Jump to search
scientific article published on 17 August 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | ADCT-301, a Pyrrolobenzodiazepine (PBD) Dimer-Containing Antibody-Drug Conjugate (ADC) Targeting CD25-Expressing Hematological Malignancies. |
scientific article published on 17 August 2016 |
Statements
ADCT-301, a Pyrrolobenzodiazepine (PBD) Dimer-Containing Antibody-Drug Conjugate (ADC) Targeting CD25-Expressing Hematological Malignancies (English)
Michael J Flynn
Francesca Zammarchi
Peter C Tyrer
Ayse U Akarca
Narinder Janghra
Charles E Britten
Carin E G Havenith
Jean-Noel Levy
Arnaud Tiberghien
Luke A Masterson
Conor Barry
Teresa Marafioti
David G Williams
Philip W Howard
Patrick H van Berkel
John A Hartley